LDTs - G2 Intelligence

Abbott and Quidel Stake Out Early Claims for Leadership of SARS-CoV-2 Rapid Antigen Testing Market

by Glenn S. Demby | Jan 6, 2021 | Articles, Essential, Industry Buzz-lir, Inside the Lab Industry-lir, Laboratory Industry Report, LDTs-lir, Recent Headlines

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

Agency Authorizes First Fully At-Home COVID-19 Testing Kit

Agency Authorizes First Fully At-Home COVID-19 Testing Kit

by Glenn S. Demby | Dec 2, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

HHS to FDA: Resume EUA Review of COVID-19 LDTs, And Do It Fast

by Glenn S. Demby | Dec 1, 2020 | Articles, Essential, Industry Buzz-lir, Inside the Lab Industry-lir, Laboratory Industry Report

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

HHS Orders FDA to Resume EUA Review of Laboratory Developed Tests for COVID-19

by Glenn S. Demby | Nov 24, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet, The Business of Testing-dtet

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

What a Biden Administration Might Portend for Regulation of Laboratory Developed Tests

by Glenn S. Demby | Nov 17, 2020 | Articles, Essential, FDA-nir, National Lab Reporter

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

« Older Entries

Next Entries »